Xtandi (enzalutamide) — NDC 0469-0625 by Astellas Pharma US, Inc.
Xtandi (enzalutamide) — NDC 0469-0625 by Astellas Pharma US, Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: Xtandi; Generic name: enzalutamide; Product NDC: 0469-0625.
| Brand name | Xtandi |
|---|---|
| Generic name | enzalutamide |
| Product NDC | 0469-0625 |
| Labeler | Astellas Pharma US, Inc. |
| Dosage form | TABLET |
| Route | ORAL |
| Active ingredients | ENZALUTAMIDE 40 mg/1 |
| Pharmacologic class | Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA] |
| Marketing category | NDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →